PBI-4050

PBI-4050

Catalog No. M10026

PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.

Size Price / USD Stock Quantity
2MG 61 Get Quote
5MG 87 Get Quote
10MG 129 Get Quote
25MG 232 Get Quote
50MG 332 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PBI-4050
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Gagnon L, et al. Am J Pathol. 2018 May;188(5):1132-1148. 2. Li Y, et al. JCI Insight. 2018 May 17;3(10). pii: 120365.
molnova catalog
related products
  • Fasiglifam

    A potent, selective, orally bioavailable GPR40 (FFA1) agonist with EC50 of 14 nM.

  • LY2922470

    LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM).

  • PBI-4050 sodium

    PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.